maintenance on tirzepatide Zepbound Dose After Goal Weight: Next Steps WEIGHT LOSS Update / LOST

Cytochrome c release assay Cells were fractionated to obtain cytoplasmic and mitochondria-enriched fractions using Dounce homogenization and differential centrifugation as per the Abcam cytochrome c release kit (ab65311)

GLP-1s offer significant benefits for many individuals living with type 2 diabetes and obesity

FDA determined on December 19, 2024 that the tirzepatide injection shortage was resolved, and on February 21, 2025 that the semaglutide injection shortage was resolved

Cost and insurance coverage remain major barriers to widespread use of GLP-1 receptor agonists in HS, as this is currently an off-label indication